Background Multiple myeloma (MM) remains an incurable cancer despite advances in
therapy. Therefore, the search for new targets is still essential to uncover potential treatment …

Multiple myeloma (MM) remains an incurable haematological malignancy despite
substantial advances in therapy. Hypoxic bone marrow induces metabolic rewiring in MM …

While multi‐drug combinations and continuous treatment have become standard for multiple
myeloma, the disease remains incurable. Repurposing drugs that are currently used for …

Abstract Acute Myeloid Leukemia (AML) is a heterogeneous disease with limited treatment
options and a high demand for novel targeted therapies. Since myeloid-related protein …

Background Immunotherapy emerged as a promising treatment option for multiple myeloma
(MM) patients. However, therapeutic efficacy can be hampered by the presence of an …

Introduction Immunotherapy has revolutionized cancer treatment and significantly affected
the management of Multiple Myeloma (MM) patients. Unfortunately, these …

Multiple myeloma (MM) remains an incurable cancer despite advances in therapy. Currently,
MM patients are treated with combinations of multiple drugs, although drug resistance …

Rationale: AXL expression has been identified as a prognostic factor in acute myeloid
leukemia (AML) and is detectable in approximately 50% of AML patients. In this study, we …

Introduction Multiple myeloma (MM) is a hematological cancer, characterized by the
accumulation of monoclonal plasma cells in the bone marrow. It remains an incurable …

Introduction Multiple myeloma (MM) remains an incurable cancer despite advances in
therapy. Therefore, the search for new targets is still essential to uncover potential treatment …